Daily Archives: 21 May 2024

Biomedical researchers edge closer to understanding the causes of eczema

Researchers at Binghamton University, State University of New York, have unveiled a study that could potentially revolutionize our understanding of eczema and pave the way for a cure. With approximately 35 million Americans and a significant global population affected by eczema, this chronic condition, also known as atopic dermatitis, is a pressing health concern. The study’s findings shed light on the underlying causes of eczema, offering a new perspective on its management and treatment.

In a collaborative effort, Associate Professor Guy German, PhD student Zachary W. Lipsky, and Associate Professor Claudia N.H. Marques has bridged two seldom-connected areas of eczema research. Their recent publication from the Thomas J. Watson School of Engineering and Applied Science’s Department of Biomedical Engineering and the Harpur College of Arts and Sciences’ Department of Biological Sciences marks a significant step forward in our understanding of this complex condition.

The study highlights that atopic dermatitis leads to reduced levels of skin oils, particularly ceramides, a group of lipids. These lipids regulate skin hydration and protect against pathogens, either by direct antimicrobial action or indirectly through immune signalling. Moreover, the research points to increased staph bacteria on the skin, which exacerbates irritation and infection.

Professor German notes the role of genetics in eczema prevalence but also identifies occupational hazards—like frequent handwashing or exposure to detergents among healthcare workers, metalworkers, hairdressers, and food processors—as factors that increase susceptibility to the condition. He poses a critical question about the consequences of reduced lipid levels on the skin due to genetic mutations or occupational exposure.

The study suggests that bacteria cannot breach the skin barrier under normal conditions. However, in conditions associated with atopic dermatitis or similar lipid deficiencies, penetration occurs within nine days. The team theorizes that staph bacteria do not merely grow around skin cells but move through them. This bacterial movement, combined with lipid depletion, compromises the skin’s barrier, increasing vulnerability to bacterial invasion and deeper skin tissue infection.

Lipsky elaborates on the protective role of skin lipids, which are traditionally associated with moisture retention. The current findings illuminate their critical function in defending against microorganisms that could cause diseases. While the study does not solve all mysteries of atopic dermatitis, it proposes that bacterial infiltration might initiate rather than result from the disease, marking a significant advancement in understanding the condition.

Further inquiries will focus on the mechanical effects of bacterial penetration on lipid-depleted skin, exploring whether it weakens the skin or enhances the likelihood of cracking and how bacteria navigate through different skin layers.

As Professor German rightly points out, every scientific answer typically raises more questions, ensuring that their research journey continues to be dynamic and exploratory. This ongoing study not only deepens the understanding of atopic dermatitis but also sets the stage for future breakthroughs in treating and managing the condition. The potential implications of this research are immense, offering hope for millions of individuals affected by eczema.

More information: Zachary W. Lipsky et al, Lipid depletion enables permeation of Staphylococcus aureus bacteria through human stratum corneum, Tissue Barriers. DOI: 10.1080/21688370.2020.1754706

Journal information: Tissue Barriers Provided by Binghamton University

The intertwining of breast cancer treatment, specifically chemotherapy, could potentially accelerate the physical deterioration in elderly individuals

A study led by UCLA suggests that older adults aged 65 or older with high-risk breast cancer who undergo chemotherapy are more prone to experiencing a significant decline in physical function. This research, published in a special issue of the Journal of Cancer Survivorship, reveals that over 30% of older women diagnosed with early-stage breast cancer and treated with chemotherapy encountered a notable reduction in their ability to perform daily activities such as walking or climbing stairs, compared to those who did not undergo chemotherapy and women of the same age without cancer.

This study stands as the first of its kind to contrast the functional decline in elderly individuals with early-stage breast cancer undergoing chemotherapy against breast cancer patients who did not receive chemotherapy, as well as age-matched women without cancer. Dr Mina Sedrak, the study’s first author and an associate professor of medicine at the David Geffen School of Medicine at UCLA, highlights the importance of this comparison in understanding whether such decline signifies an acceleration of the ageing process itself.

Breast cancer, particularly in older women, often leads to accelerated ageing and a decline in physical abilities. This phenomenon, termed accelerated ageing, can significantly impact individuals’ quality of life, independence, and even lifespan. Given the projected increase in the number of older breast cancer survivors — expected to surpass 6 million by 2040 — comprehending the mechanisms of accelerated ageing and devising strategies to mitigate it becomes paramount.

To delve deeper into the repercussions of breast cancer treatment on ageing-related declines in physical function, the researchers conducted a multicenter prospective study. They compared changes in physical function over time in women aged over 65, involving 444 women with early-stage breast cancer receiving chemotherapy, 98 receiving non-chemotherapy treatments, and 100 women without cancer of similar age.

Participants underwent two assessments: completing questionnaires on demographics and health status and a geriatric assessment. For breast cancer patients, additional data on cancer-specific and treatment-related characteristics were obtained from medical records. The second assessment, including another round of the geriatric evaluation, occurred within 30 days of completing chemotherapy for the chemotherapy group or at matched time points for the other two groups.

The analysis revealed that 30% of elderly adults receiving chemotherapy for breast cancer experienced a significant decline in physical function, compared to 8% among those who did not receive chemotherapy and 5% among those without cancer. Among those experiencing a notable decline, climbing stairs was the activity most adversely affected (75.7%), followed by walking one mile (73.0%) and engaging in moderate activity (68.6%).

These findings suggest that the combination of high-risk breast cancer and chemotherapy contributes to an accelerated decline in physical function among older adults with early-stage breast cancer. Dr. Sedrak emphasizes the impact of cancer and its treatment on physical function in older women, underscoring the importance of preserving physical function throughout the cancer journey.

The research team now aims to elucidate the biological mechanisms underlying the interplay between cancer treatment and fundamental ageing processes. Specifically, they are investigating cellular senescence and identifying mechanisms that could be targeted by drugs to potentially reverse these processes, offering hope for improving the quality of life for elderly breast cancer patients.

More information: Mina S. Sedrak et al, Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study, Journal of Cancer Survivorship. DOI: 10.1007/s11764-024-01594-3

Journal information: Journal of Cancer Survivorship Provided by University of California, Los Angeles